[1]郑仁东 张会峰 胡咏新 曹雯 曹琳 孙洪平 褚晓秋 刘克冕 刘超.男性2型糖尿病患者甲状腺结节 与内分泌激素的相关性研究[J].国际内分泌代谢杂志,2018,38(04):222-227.[doi:10.3760/cma.j.issn.1673-4157.2018.04.002]
　Zheng Rendong,Zhang Huifeng,Hu Yongxin,et al.Association of thyroid nodules with endocrine hormones in male patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2018,38(04):222-227.[doi:10.3760/cma.j.issn.1673-4157.2018.04.002]
点击复制

男性2型糖尿病患者甲状腺结节 与内分泌激素的相关性研究()
分享到：

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
38
期数:
2018年04期
页码:
222-227
栏目:
论著
出版日期:
2018-07-20

文章信息/Info

Title:
Association of thyroid nodules with endocrine hormones in male patients with type 2 diabetes mellitus
作者:
郑仁东 张会峰 胡咏新 曹雯 曹琳 孙洪平 褚晓秋 刘克冕 刘超
210028 南京中医药大学附属中西医结合医院内分泌代谢病院区
Author(s):
Zheng Rendong;  Zhang Huifeng;  Hu Yongxin;  Cao Wen;  Cao Lin;  Sun Hongping;  Chu Xiaoqiu;  Liu Kemian;  Liu Chao
Endocrine and Diabetes Center, Jiangsu Province Hospital on Integration of Chinese and Western Medicine, Nanjing University of Traditional Chinese Medicine, Nanjing 210028, China
关键词:
甲状腺结节;  男性;  2型糖尿病;  胰岛素抵抗;  甲状腺激素;  性激素
Keywords:
Thyroid nodules;  Male;  Type 2 diabetes mellitus;  Insulin resistance;  Thyroid hormones;  Gonadal hormone
DOI:
10.3760/cma.j.issn.1673-4157.2018.04.002
摘要:
目的 观察男性2型糖尿病患者甲状腺结节与内分泌激素水平的关系。方法 490例男性2型糖尿病患者被分为甲状腺结节组228例(192例结节性良性结节,30例囊性结节,6例甲状腺癌),无甲状腺结节组(262例)。根据甲状腺结节大小,分为:结节<1.0 cm组,结节1.0～2.0 cm组,结节>2.0 cm组。检测各组血糖、血脂、血清胰岛素、甲状腺功能、性激素和肾上腺激素水平。分析激素水平与甲状腺结节的相关性。结果 与无甲状腺结节组相比,甲状腺结节组空腹胰岛素(FINS)、稳态模型评估-胰岛素抵抗指数(HOMA-IR)、促甲状腺激素(TSH)和黄体生成素(LH)水平明显升高(t=2.65～3.59, P均<0.05); 而且所有甲状腺结节亚组FINS、HOMA-IR、TSH和LH水平较高,与结节<1.0 cm 组相比,结节>2.0 cm 组FINS、HOMA-IR、TSH和LH水平升高(F=8.26、5.39、7.65、9.32,P均<0.05); 按三分位法进行分组,高水平FINS组、高水平HOMA-IR组、高水平TSH组、高水平LH组甲状腺结节的发病率均显著增加(χ2=4.37、5.29、6.54、3.36,P均<0.05); Pearson相关性分析发现,甲状腺结节大小与FINS、HOMA-IR、TSH、LH水平呈正相关(r=0.215、0.387、0.382、0.181,P均<0.05); logistic回归分析发现FINS(OR=1.252,95%CI:1.164～1.295,P<0.05)、HOMA-IR(OR=1.326,95%CI: 1.053～1.352)、TSH(OR=1.217,95%CI: 1.021～1.159, P<0.05)和LH(OR=1.358, 95%CI: 1.063～1.174, P<0.05)是甲状腺结节的独立危险因素。结论 内分泌激素水平失衡在甲状腺结节的发病机制中起重要作用,FINS、HOMA-IR、TSH和LH是男性2型糖尿病患者甲状腺结节的独立危险因素。
Abstract:
Objective To investigate the association between thyroid nodules and levels of endocrine hormones in male patients with type 2 diabetes.Methods A total of 490 male patients with type 2 diabetes mellitus were enrolled, and were divided into thyroid nodule group(n=228, 192 had a solid benign nodule, 30 had a cystic nodule, and 6 had a cancerous nodule)and non-thyroid nodule group(n=262). According to the size of thyroid nodule, all patients were further divided into small nodule group(<1.0 cm), medium nodule group(1.0-2.0 cm)and big nodule group(>2.0 cm). Blood glucose, blood lipids, serum insulin, thyroid function, sex hormones and adrenal hormone were measured in all groups. The correlations between hormone levels and thyroid nodules were analyzed.Results Compared with non-thyroid nodule group, levels of fasting insulin level(FINS), homeostasis model assessment of insulin resistance(HOMA-IR), thyroid stimulating hormone(TSH)and luteinizing hormone(LH)were significantly elevated in thyroid nodule group(t= 2.65-3.59, all P<0.05). The levels of FINS, HOMA-IR, TSH and LH were higher in all thyroid nodule sub-groups; compared with small nodule group,the levels of FINS, HOMA-IR, TSH and LH were statistically significant in big nodule group(F=8.26,5.39,7.65,9.32,all P<0.05). The incidence of thyroid nodules increased significantly in patients with high levels of FINS, HOMA-IR, TSH and LH(χ2=4.37, 5.29,6.54,3.36,all P<0.05). Pearson correlation analysis found that the incidence of thyroid nodules was positively correlated with the levels of FINS, HOMA-IR, TSH and LH(r=0.215,0.387,0.382,0.181,all P<0.05). Logistic regression analysis revealed that FINS(OR=1.252, 95%CI:1.164-1.295, P<0.05), HOMA-IR(OR=1.326, 95%CI: 1.053-1.352), TSH(OR=1.217, 95%CI: 1.021-1.159, P<0.05)and LH(OR=1.358, 95%CI: 1.063-1.174, P<0.05)were independent risk factors for thyroid nodules.Conclusions The imbalance of endocrine hormone levels plays an important role in the development of thyroid nodules. FINS, HOMA-IR, TSH and LH are independent risk factors for thyroid nodules in male patients with type 2 diabetes.

参考文献/References:


[1] Junik R,Kozinski M,Debska-Kozinska K.Thyroid ultrasound in diabetic patients without overt thyroid disease[J].Acta Radiol,2006,47(7):687-691.DOI:10.1080/02841850600806308.
[2] Duran AO,Anil C,Gursoy A,et al.The relationship between glucose metabolism disorders and malignant thyroid disease[J].Int J Clin Oncol,2013,18(4):585-589.DOI:10.1007/s10147-012-0435-3.
[3] Lee ZS,Chan JC,Yeung VT,et al.Plasma insulin, growth hormone, cortisol, and central obesity among young Chinese type 2 diabetic patients[J].Diabetes Care,1999,22(9):1450-1457.
[4] Anil C,Akkurt A,Ayturk S,et al.Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area[J].Metabolism,2013,62(7):970-975.DOI:10.1016/j.metabol.2013.01.009.
[5] Wallace TM,Levy JC,Matthews DR.Use and abuse of HOMA modeling[J].Diabetes Care,2004,27(6):1487-1495.
[6] Guo H,Sun M,He W,et al.The prevalence of thyroid nodules and its relationship with metabolic parameters in a Chinese community-based population aged over 40 years[J].Endocrine,2014,45(2):230-235.DOI:10.1007/s12020-013-9968-0.
[7] Zheng L,Yan W,Kong Y,et al.An epidemiological study of risk factors of thyroid nodule and goiter in Chinese women[J].Int J Environ Res Public Health,2015,12(9):11608-11620.DOI:10.3390/ijerph120911608.
[8] Sari R,Balci MK,Altunbas H,et al.The effect of body weight and weight loss on thyroid volume and function in obese women[J].Clin Endocrinol(Oxf),2003,59(2):258-262.
[9] Wang K,Yang Y,Wu Y,et al.The association between insulin resistance and vascularization of thyroid nodules[J].J Clin Endocrinol Metab,2015,100(1):184-192. DOI:10.1210/jc.2014-2723.
[10] Yasar HY,Ertugˇrul O,Ertugˇrul B,et al.Insulin resistance in nodular thyroid disease[J].Endocr Res,2011,36(4):167-174.DOI:10.3109/07435800.2011.593011.
[11] Pappa T,Alevizaki M.Obesity and thyroid cancer: a clinical update[J].Thyroid,2014,24(2):190-199.DOI:10.1089/thy.2013.0232.
[12] Rezzónico J,Rezzónico M,Pusiol E,et al.Metformin treatment for small benign thyroid nodules in patients with insulin resistance[J].Metab Syndr Relat Disord,2011,9(1):69-75.DOI:10.1089/met.2010.0026.
[13] Chen G,Xu S,Renko K,et al.Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents[J].J Clin Endocrinol Metab,2012,97(4):E510-E520.DOI:10.1210/jc.2011-1754.
[14] Rajoria S,Suriano R,Parmar PS,et al.3,3'-diindolylmethane modulates estrogen metabolism in patients with thyroid proliferative disease: a pilot study[J].Thyroid,2011,21(3):299-304.DOI:10.1089/thy.2010.0245.
[15] Manole D,Schildknecht B,Gosnell B,et al.Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms[J].J Clin Endocrinol Metab,2001,86(3):1072-1077.DOI:10.1210/jcem.86.3.7283.
[16] Liu J,Chen G,Meng XY,et al.Serum levels of sex hormones and expression of their receptors in thyroid tissue in female patients with various types of thyroid neoplasms[J].Pathol Res Pract,2014,210(12):830-835.DOI:10.1016/j.prp.2014.09.002.
[17] Govindaraj V,Arya SV,Rao AJ.Differential action of glycoprotein hormones: significance in cancer progression[J].Horm Cancer,2014,5(1):1-10.DOI:10.1007/s12672-013-0164-8.
[18] Liao H,Zhou Q,Gu Y,et al.Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway[J].Oncol Rep,2012,27(6):1873-1878.DOI:10.3892/or.2012.1745.
[19] Oguz A,Tuzun D,Sahin M,et al.Should human chorionic gonadotropine treatment increase thyroid volume?[J].Arch Endocrinol Metab,2015,59(6):482-486.DOI:10.1590/2359-3997000000096.
[20] Fiore E,Vitti P.Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease[J].J Clin Endocrinol Metab,2012,97(4):1134-1145.DOI:10.1210/jc.2011-2735.
[21] Samadi A,Loo P,Mukerji R,et al.A novel HSP90 modulator with selective activity against thyroid cancers in vitro[J].Surgery,2009,146(6):1196-1207.DOI:10.1016/j.surg.2009.09.028.
[22] Sdano MT,Falciglia M,Welge JA,et al.Efficacy of thyroid hormone suppression for benign thyroid nodules: meta-analysis of randomized trials[J].Otolaryngol Head Neck Surg,2005,133(3):391-396.DOI:10.1016/j.otohns.2005.06.007.
[23] Haymart MR,Repplinger DJ,Leverson GE,et al.Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage[J].J Clin Endocrinol Metab,2008,93(3):809-814.DOI:10.1210/jc.2007-2215.
[24] Chrisoulidou A,Pazaitou-Panayiotou K,Georgiou E,et al.The hypothalamic-pituitary-adrenal axis in women with differentiated thyroid cancer[J].Endocr Res,2010,35(3):137-143.DOI:10.3109/07435800.2010.496760.

相似文献/References:

[1]杨成会,缪珩.二甲双胍在甲状腺疾病治疗中的作用[J].国际内分泌代谢杂志,2015,(04):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
　Yang Chenghui,Miao Heng..Roles of metformin in the treatment of thyroid diseases[J].International Journal of Endocrinology and Metabolism,2015,(04):255.[doi:10.3760/cma.j.issn.1673-4157.2015.04.011]
[2]梁绮君 余寿益 李淑华 胡晨鸣 杨焱.甲状腺结节与代谢综合征的相关性研究[J].国际内分泌代谢杂志,2015,(05):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
　Liang Qijun,Yu Shouyi,Li Shuhua,et al.Association of thyroid nodule and metabolic syndrome[J].International Journal of Endocrinology and Metabolism,2015,(04):293.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.002]
[3]曹雯,郑仁东,曹琳,等.男性2型糖尿病患者血尿酸与性激素 相关性研究[J].国际内分泌代谢杂志,2016,36(01):28.[doi:10.3760/cma.j.issn.1673-4157.2016.01.007]
　Cao Wen,Zheng Rendong,Cao Lin,et al.Correlation between blood uric acid and sex hormones in male patients with type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(04):28.[doi:10.3760/cma.j.issn.1673-4157.2016.01.007]
[4]陈茉 徐书杭 刘超.良性甲状腺结节的热消融治疗进展[J].国际内分泌代谢杂志,2019,39(04):248.[doi:10.3760/cma.j.issn.1673-4157.2019.04.008]
　Chen Mo,Xu Shuhang,Liu Chao.Advancement of thermal ablation on benign thyroid nodules[J].International Journal of Endocrinology and Metabolism,2019,39(04):248.[doi:10.3760/cma.j.issn.1673-4157.2019.04.008]
[5]周一帆 季沁 陈国芳 褚晓秋 陈茉 丁文波 胡欣 相萍萍 曾铮 王建华 徐书杭 刘超.TI-RADS对细胞学结果不确定甲状腺结节的诊断价值[J].国际内分泌代谢杂志,2019,39(04):226.[doi:10.3760/cma.j.issn.1673-4157.2019.04.003]
　Zhou Yifan,Ji Qin,Chen Guofang,et al.Clinical value of TI-RADS in the diagnosis of thyroid nodules with indeterminate cytology[J].International Journal of Endocrinology and Metabolism,2019,39(04):226.[doi:10.3760/cma.j.issn.1673-4157.2019.04.003]
[6]周一帆 王建华 徐书杭.甲状腺细胞病理学Bethesda报告系统的更新及研究进展[J].国际内分泌代谢杂志,2020,40(03):175.[doi:10.3760/cma.j.issn.1673-4157.2020.03.007]
　Zhou Yifan,Wang Jianhua,Xu Shuhang.Update and research progress of the Bethesda system for reporting thyroid cytopathology[J].International Journal of Endocrinology and Metabolism,2020,40(04):175.[doi:10.3760/cma.j.issn.1673-4157.2020.03.007]
[7]杨晶晶,徐书杭,刘超.针穿活检用于甲状腺结节诊断的研究进展[J].国际内分泌代谢杂志,2021,41(01):20.[doi:10.3760/cma.j.cn121383-20200511-05018]
　Yang Jingjing,Xu Shuhang,et al.Update on core needle biopsy in the diagnosis of thyroid nodules[J].International Journal of Endocrinology and Metabolism,2021,41(04):20.[doi:10.3760/cma.j.cn121383-20200511-05018]
[8]田勍,洪天配.甲状腺结节诊治过程中的难点与应对[J].国际内分泌代谢杂志,2021,41(06):557.[doi:10.3760/cma.j.cn121383-20210727-07074]
　Tian Qing,Hong Tianpei..Difficulties and countermeasures in the diagnosis and treatment of thyroid nodules[J].International Journal of Endocrinology and Metabolism,2021,41(04):557.[doi:10.3760/cma.j.cn121383-20210727-07074]
[9]张雅,相萍萍,徐书杭,等.经皮无水乙醇注射治疗甲状腺结节:老方法的新认识[J].国际内分泌代谢杂志,2022,42(06):469.[doi:10.3760/cma.j.cn121383-20210926-09075]
　Zhang Ya,Xiang Pingping,Xu Shuhang,et al.Percutaneous ethanol ablation for thyroid nodules: new perspectives on an old paradigm[J].International Journal of Endocrinology and Metabolism,2022,42(04):469.[doi:10.3760/cma.j.cn121383-20210926-09075]
[10].甲状腺结节和分化型甲状腺癌诊治指南(第二版)[J].国际内分泌代谢杂志,2023,43(02):149.[doi:10.3760/cma.j.cn311282-20221023-00589]
　Chinese Society of Endocrinology,Thyroid and Metabolism Surgery Group of the Chinese Society of Surgery,China Anti-Cancer Association,et al.Guidelines for the Diagnosis and Management of Thyroid Nodules and Differentiated Thyroid Cancer(Second Edition)[J].International Journal of Endocrinology and Metabolism,2023,43(04):149.[doi:10.3760/cma.j.cn311282-20221023-00589]

备注/Memo

备注/Memo:

通信作者:刘超,Email: profliuchao@163.com
更新日期/Last Update: 2018-04-30